Jun 11, 2020
Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus
Apr 16, 2020
HEMEMICS Biotechnologies, Inc. Receives HHS Support to Develop Rapid Antigen, Antibody Diagnostic to Identify COVID-19 Infected Americans
Mar 20, 2020
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
Jan 15, 2020
INTELLiSTEM Announces the Launch of a New Antigen Identification Platform for the Development of Novel Car T Cells
Nov 06, 2019
Ervaxx Launches to Pioneer the Use of Dark Antigens(TM) for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies
Jun 25, 2019
Pepscan Produces Clinical Peptides for Innovative Personalized Cancer Vaccine Trial
Jun 19, 2019
Nouscom Demonstrates Preclinical Proof of Concept for Personalized Cancer Neoantigen Vaccine in Combination With Immune Checkpoint Blockade to Eradicate Large Tumors
May 30, 2019
Global Tumor-Specific Antigen Market Report 2019: 2017-2018 Data & CAGR Projections Through 2023
Apr 16, 2019
Key Patent Issued for Xyphos Biosciences' ACCEL(TM) Technology Platform
Mar 25, 2019
EpiVax Oncology To Present Latest Research On The Importance Of Identifying And Removing, Using Machine-Learning Based Advanced Computational Tools, Inhibitory Neoantigens From Therapeutic Cancer Vaccines, At AACR Annual Meeting 2019
Jan 07, 2019
Adagene Announces Collaboration for Discovery of Novel CAR-T with the National Heart, Lung, and Blood Institute at the National Institute of Health (NIH)
Oct 30, 2018
New Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene
Oct 15, 2018
SQZ Biotech Expands Cell Therapy Partnership with Roche to Develop Antigen Presenting Cells for Immune-Oncology
Oct 09, 2018
Torque Builds Out Management Team with Immunology, Clinical Development, and Manufacturing Leadership
Jul 23, 2018
GigaMune Secures Collaboration with Mass General for Development of Cell Therapies for Cancer
May 02, 2018
EpicentRx Announces First Ever Treatment of Cancer Patient with Personalized, Custom-Made Viral Vaccines
Dec 11, 2017
Morphotek And Rockefeller University Form A Sponsored Research Agreement To Study The Immunosuppressive Effects Of The Tumor Shed Antigen CA125 And Its Potential Impact In Future Patient Therapies
Oct 25, 2017
New Study: 'Double Decker' Antibody Technology Fights Cancer
Aug 29, 2017
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2017
Aug 29, 2017
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2017